keyword
https://read.qxmd.com/read/38504000/organ-specific-accuracy-of-18-f-fdg-pet-ct-in-identifying-immune-related-adverse-events-in-patients-with-high-risk-melanoma-treated-with-adjuvant-immune-checkpoint-inhibitor
#21
JOURNAL ARTICLE
Birte Molvik Gideonse, Magnus Birkeland, Mie Holm Vilstrup, Peter Grupe, Mohammad Naghavi-Behzad, Christina H Ruhlmann, Oke Gerke, Malene Grubbe Hildebrandt
PURPOSE: This study aimed to determine the organ-specific accuracy of [18 F]FDG-PET/CT in identifying immune-related adverse events (irAEs) in patients with high-risk (stage III/IV) surgically resected melanoma treated with an adjuvant immune checkpoint inhibitor (ICI) and determine the incidence of irAEs within the first year after starting treatment. MATERIALS AND METHODS: This registry-based study included individuals who had undergone surgical removal of melanoma and were undergoing adjuvant ICI treatment (either nivolumab or pembrolizumab)...
March 20, 2024: Japanese Journal of Radiology
https://read.qxmd.com/read/38500872/benefit-recurrence-pattern-and-toxicity-to-adjuvant-anti-pd-1-monotherapy-varies-by-ethnicity-and-melanoma-subtype-an-international-multicenter-cohort-study
#22
JOURNAL ARTICLE
Xue Bai, Aleigha R Lawless, Juliane A Czapla, Stefanie C Gerstberger, Benjamin C Park, Seungyeon Jung, Rebecca Johnson, Naoya Yamazaki, Dai Ogata, Yoshiyasu Umeda, Caili Li, Jun Guo, Keith T Flaherty, Yasuhiro Nakamura, Kenjiro Namikawa, Georgina V Long, Alexander M Menzies, Douglas B Johnson, Ryan J Sullivan, Genevieve M Boland, Lu Si
BACKGROUND: Anti-Program-Death-1 (PD-1) is a standard adjuvant therapy for patients with resected melanoma. We hypothesized that there are discrepancies in survival, recurrence pattern and toxicity to adjuvant PD-1 between different ethnicities and melanoma subtypes. OBJECTIVE: We performed a multicenter cohort study incorporating 6 independent institutions in Australia, China, Japan, and the United States. The primary outcomes were recurrence free survival (RFS) and overall survival (OS)...
June 2024: JAAD international
https://read.qxmd.com/read/38497054/combining-surgery-radiotherapy-and-topical-chemotherapy-to-prevent-primary-orbital-exenteration-for-atypical-caruncular-melanoma-a-case-report
#23
Cédric De Landsheer, Valentien Merlevede, Celine Jacobs, Jo Van Dorpe, Julie De Zaeytijd, Virginie G S Ninclaus, Dimitri Roels
INTRODUCTION: This case report demonstrates the possibility of successful eye and vision-sparing therapy for caruncular melanoma. CASE PRESENTATION: We present an atypical presentation of a caruncular melanoma. After excisional biopsy, residual flat conjunctival melanosis resolved using topical chemotherapy (5-fluorouracil), which was well tolerated. Relapse of the melanoma was treated with external beam radiotherapy, but the tumor grew despite treatment. Eighteen months after complete excision of the relapsed melanoma, the patient remains tumor-free while the eye and its function remain preserved...
2024: Case Reports in Ophthalmology
https://read.qxmd.com/read/38496632/radiation-and-anti-pd-l1-synergize-by-stimulating-a-stem-like-t-cell-population-in-the-tumor-draining-lymph-node
#24
Zachary Buchwald, Yang Shen, Erin Connolly, Meili Aiello, Chengjing Zhou, Prasanthi Chappa, Haorui Song, Patan Tippitak, Tarralyn Clark, Maria Cardenas, Nataliya Prokhnevska, Annapaola Mariniello, Meghana Pagadala, Vishal Dhere, Sarwish Rafiq, Aparna Kesarwala, Alexandre Orthwein, Susan Thomas, Mohammad Khan, J Brandon Dixon, Gregory B Lesinski, Michael Lowe, Haydn Kissick, David Yu, Chrystal Paulos, Nicole Schmitt
Radiotherapy (RT) and anti-PD-L1 synergize to enhance local and distant (abscopal) tumor control. However, clinical results in humans have been variable. With the goal of improving clinical outcomes, we investigated the underlying synergistic mechanism focusing on a CD8+ PD-1+ Tcf-1+ stem-like T cell subset in the tumor-draining lymph node (TdLN). Using murine melanoma models, we found that RT + anti-PD-L1 induces a novel differentiation program in the TdLN stem-like population which leads to their expansion and differentiation into effector cells within the tumor...
March 6, 2024: Research Square
https://read.qxmd.com/read/38494565/leg-lymphoedema-after-inguinal-and-ilio-inguinal-lymphadenectomy-for-melanoma-results-from-a-prospective-randomised-trial
#25
JOURNAL ARTICLE
T S Lee, I Li, B Peric, R P M Saw, J P Duprat, E Bertolli, J B Spillane, B L van Leeuwen, M Moncrieff, A Sommariva, C P Allan, J H W de Wilt, R Pritchard- Jones, J L C Geh, J R Howle, A J Spillane
BACKGROUND: The Evaluation of Groin Lymphadenectomy Extent for Melanoma (EAGLE FM) study sought to address the question of whether to perform inguinal (IL) or ilio-inguinal lymphadenectomy (I-IL) for patients with inguinal nodal metastatic melanoma who have no clinical or imaging evidence of pelvic disease. Primary outcome measure was disease-free survival at 5 years, and secondary endpoints included lymphoedema. METHODS: EAGLE FM was designed to recruit 634 patients but closed with 88 patients randomised because of slow recruitment and changes in melanoma management...
March 17, 2024: Annals of Surgical Oncology
https://read.qxmd.com/read/38473430/current-and-emerging-radiotherapy-options-for-uveal-melanoma
#26
REVIEW
Oleksii Semeniuk, Esther Yu, Mark J Rivard
What treatment options are there for patients having uveal melanoma? A randomized, prospective, multi-institutional clinical trial (COMS) showed no difference in survival between brachytherapy and enucleation for medium-sized lesions. With the obvious benefit of retaining the eye, brachytherapy has flourished and many different approaches have been developed such as low-dose-rate sources using alternate low-energy photon-emitting radionuclides, different plaque designs and seed-loading techniques, high-dose-rate brachytherapy sources and applicators, and low- and high-dose-rate beta-emitting sources and applicators...
March 6, 2024: Cancers
https://read.qxmd.com/read/38455253/demographics-aspects-of-brain-and-spine-metastatic-melanoma-retrospective-analysis-in-a-single-third-level-center
#27
JOURNAL ARTICLE
Daniel Alejandro Vega-Moreno, Shunichiro Kuramitsu, Eguchi Kaoru, Kajita Yasukazu, Ulises García-González, Abraham Ibarra-de la Torre, Liliana Hernández-Hernández, Rosa María Vicuña-González, Martha Elena González-Jiménez
BACKGROUND: Melanoma metastases to the CNS rank third in frequency, just after lung and breast metastases. There is controversy regarding the factors predisposing to developing CNS metastases in patients with cutaneous melanoma and their survival with conventional treatments. METHODS: We carried out a retrospective analysis in a third-level hospital in Mexico to determine epidemiological aspects of melanoma metastases to the central nervous system, factors related to its appearance, clinical presentation, and survival in three treatment groups: surgery, radiotherapy, and conservative management...
April 2024: World neurosurgery: X
https://read.qxmd.com/read/38454124/polygenic-risk-scores-radiation-treatment-exposures-and-subsequent-cancer-risk-in-childhood-cancer-survivors
#28
JOURNAL ARTICLE
Todd M Gibson, Danielle M Karyadi, Stephen W Hartley, Michael A Arnold, Amy Berrington de Gonzalez, Miriam R Conces, Rebecca M Howell, Vidushi Kapoor, Wendy M Leisenring, Joseph P Neglia, Joshua N Sampson, Lucie M Turcotte, Stephen J Chanock, Gregory T Armstrong, Lindsay M Morton
Survivors of childhood cancer are at increased risk for subsequent cancers attributable to the late effects of radiotherapy and other treatment exposures; thus, further understanding of the impact of genetic predisposition on risk is needed. Combining genotype data for 11,220 5-year survivors from the Childhood Cancer Survivor Study and the St Jude Lifetime Cohort, we found that cancer-specific polygenic risk scores (PRSs) derived from general population, genome-wide association study, cancer loci identified survivors of European ancestry at increased risk of subsequent basal cell carcinoma (odds ratio per s...
March 7, 2024: Nature Medicine
https://read.qxmd.com/read/38450592/novosorb%C3%A2-biodegradable-temporising-matrix-btm-in-the-reconstruction-of-cutaneous-malignancies-in-a-major-cancer-centre-a-case-series
#29
JOURNAL ARTICLE
Maxim Devine, Mark Edmondson, Peter Gearing, Elizabeth Concannon, Michael Findlay, Richard Zinn, Angela Webb
BACKGROUND: Non-graftable or composite defect reconstruction represents a major challenge to the reconstructive surgeon, with many wounds requiring local flap or free microvascular tissue transfer approaches. The recent advent of synthetic skin substitutes such as Biodegradable Temporizing Matrix (BTM) have revolutionized the management of complex defects including those caused by burns, trauma and infection, with low-morbidity and low-complexity surgery. However, limited data exist supporting their use in cancer reconstruction in Australia...
March 7, 2024: ANZ Journal of Surgery
https://read.qxmd.com/read/38449655/global-research-landscape-and-trends-of-cancer-radiotherapy-plus-immunotherapy-a-bibliometric-analysis
#30
JOURNAL ARTICLE
Yanhao Liu, Xu Jiang, Yujuan Wu, Haiming Yu
The aim of this study was to present current research trends on the synergistic use of radiotherapy and immunotherapy (IRT) for cancer treatment. On March 1, 2023, we conducted a literature search for IRT papers using the Web of Science database. We extracted information and constructed two databases - the Core Database (CD) with 864 papers and Generalized Database (GD) with 6344 papers. A bibliometric analysis was performed to provide insights into the research landscape, to identify emerging trends and highly cited papers and journals in the field of IRT...
March 15, 2024: Heliyon
https://read.qxmd.com/read/38439727/merkel-cell-carcinoma-of-unknown-primary-origin
#31
JOURNAL ARTICLE
Helena Francetić, Luka Simetić, Čedna Tomasović Lončarić, Daška Štulhofer Buzina, Romana Čeović
Merkel cell carcinoma (MCC) is a rare and highly aggressive primary cutaneous neuroendocrine carcinoma most often occurring in the elderly. Risk factors include chronic sun exposure and immunosuppression (1). MCC is associated with frequent recurrences and a high metastatic potential and mortality rate (1). It is the second most common cause of skin-cancer-related death after melanoma. At primary diagnosis with an apparent cutaneous tumor, loco-regional metastases are present in up to 30% of patients, and 6-12% have distant metastatic disease (2-3)...
December 2023: Acta Dermatovenerologica Croatica: ADC
https://read.qxmd.com/read/38439628/primary-nasopharyngeal-melanoma-without-invasive-and-metastasis-a-rare-case-reports-and-literature-reviews
#32
JOURNAL ARTICLE
Jian-Jun Wang, Yao-Dong Huan, Hua Liu
Objective: Nasopharyngeal melanoma is a rare mucosal malignant melanoma with high recurrence rate, metastasis rate and vascular invasion rate. In this paper, we report a case of primary nasopharyngeal mucosal melanoma. Methods: A case of primary nasopharyngeal mucosal melanoma was reported, and its clinical symptoms, pathological characteristics, treatment and follow-up were described in detail. Results: This report describes a 59-year-old male patient with persistent nasal congestion and suspected malignant nasopharyngeal neoplasm...
March 4, 2024: Ear, Nose, & Throat Journal
https://read.qxmd.com/read/38437862/subdural-hematoma-due-to-dural-metastasis-a-systematic-review-on-frequency-clinical-characteristics-and-neurosurgical-management
#33
JOURNAL ARTICLE
Bhavya Pahwa, Anish Tayal, Atulya Chandra, Joe M Das
BACKGROUND:  Subdural hematoma (SDH) occasionally accompanies dural metastasis and is associated with high recurrence rate, significantly impacting patient morbidity and mortality. This systematic review aims to evaluate the characteristics, management options, and outcomes of patients with SDH associated with dural metastasis. METHODS:  A comprehensive search of the PubMed and Cochrane databases was conducted for English-language studies published from inception to March 20, 2023, adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines...
March 4, 2024: Journal of Neurological Surgery. Part A, Central European Neurosurgery
https://read.qxmd.com/read/38418154/effect-of-jaw-tracking-during-volumetric-modulated-arc-therapy-for-facial-non-melanoma-skin-cancer
#34
JOURNAL ARTICLE
So Hyun Park, Hyunsoo Ko, Jinhyun Choi
BACKGROUND/AIM: This study aimed to analyze the dosimetric effects of jaw tracking during Volumetric Modulated Arc Therapy (VMAT) planning for facial non-melanoma skin cancer (NMSC). PATIENTS AND METHODS: This study included 50 patients with facial NMSC who underwent VMAT planning with or without jaw tracking. The target volume (TV) included the primary skin lesion with a 1-cm margin around the surface and a depth of 4 mm. A total of 55 Gy in 20 fractions was prescribed, and the plans were considered acceptable if the TV was covered by 95-105% of the isodose curve...
2024: In Vivo
https://read.qxmd.com/read/38403520/clinical-value-of-whole-body-18-f-fdg-pet-ct-imaging-in-patients-with-cutaneous-melanoma-a-multi-center-cohort-study
#35
JOURNAL ARTICLE
Nichole Bower, Amy Morris, Janet O'Connor, Melissa Sponagle, Rebekah Bahr, Robert Gilbert, Abdolell Mohamed, Jonathan Bower
BACKGROUND: 18 F-FDG-PET/CT is a valuable tool in the staging and surveillance of cutaneous melanoma; however, recent studies prompt debate on the clinical significance of imaging patients below the lesser trochanter. This study explored two research questions. In patients with a known primary cutaneous melanoma within the standard field of view (SFOV, between the orbits and lesser trochanter), what is the prevalence of metastasis to sites solely within the lower extremities? and, In patients with a known primary cutaneous melanoma within the SFOV what demographic and clinical factors are associated with sole metastasis to the lower extremities? METHODS: A retrospective, multi-centered, observational study of consecutive case reports was conducted...
February 24, 2024: Journal of Medical Imaging and Radiation Sciences
https://read.qxmd.com/read/38400783/a-prognostic-model-for-cancer-specific-survival-among-patients-with-nodular-melanoma-in-head-and-neck
#36
JOURNAL ARTICLE
Fangli Fan, Juxiang Gou, Shulian Li, Qiang Ji
OBJECTIVES: This study aims to evaluate the correlation between risk factors and treatment methods affecting nodular melanoma (NM) in the head and neck, as well as cancer-specific survival (CSS), and provide personalized predictive tools for clinical physicians. METHODS: The retrospective study data of 1848 patients were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. All variables were included in the correlation analysis using the Spearman method...
February 24, 2024: Laryngoscope
https://read.qxmd.com/read/38391320/angiosarcoma-of-the-head-and-neck-a-clinicopathologic-study-with-special-emphasis-on-diagnostic-pitfalls
#37
JOURNAL ARTICLE
Jayapriya Gangadharan, Anitha Mathews, Sindhu N Prasanna Kumary, Thara Somanathan, K Jayasree, Geetha Narayanan
BACKGROUND AND AIMS: Angiosarcoma (AS) is a rare malignant vascular tumor that phenotypically and functionally recapitulate normal endothelium. They constitute approximately 2-4% of soft tissue sarcomas. We present 36 cases of head and neck AS diagnosed for 11 years at a tertiary care hospital in South India to analyze the clinical, pathological, and immunophenotypic profiles with special emphasis on their differential diagnoses and diagnostic pitfalls. MATERIALS AND METHODS: Head and neck AS diagnosed from January 2006 to December 2017 were included...
February 14, 2024: Indian Journal of Pathology & Microbiology
https://read.qxmd.com/read/38389591/disease-progression-and-death-from-cervical-melanoma-in-a-patient-undergoing-nivolumab-therapy-a-case-report
#38
Mateus Lopes Macêdo, Rafael Everton Assunção Ribeiro da Costa, Cristiane Amaral Dos Reis, Raimundo Gerônimo Da Silva Júnior, Ary Oliveira Pires, Sabas Carlos Vieira
Melanoma of the uterine cervix is an exceedingly rare malignancy that has high recurrence rates and distant metastases. In general, surgery is the preferred treatment for this tumor, and depending on stage additional consideration to radiotherapy and chemotherapy. Immunotherapy has emerged as a new treatment option in this context. The aim of this study was to report a case of melanoma of the uterine cervix that progressed rapidly to death while the patient was undergoing immunotherapy with nivolumab. A 39-year-old woman presented with an amelanotic ulcerated lesion of the uterine cervix in February of 2023...
January 2024: Curēus
https://read.qxmd.com/read/38387413/craniectomy-with-soft-tissue-reconstruction-for-locally-advanced-non-melanoma-skin-cancer-of-scalp-with-calvarial-invasion-the-nottingham-experience
#39
JOURNAL ARTICLE
Zhen Y Wong, Neil Wickham, Shenbana Bagirathan, Alex Leggate, Stuart J Smith, Jonathan Pollock
INTRODUCTION: Locally advanced non-melanoma skin cancer (NMSC) involving the periosteum or calvarium poses a clinical challenge for patients who are unfit for immunotherapy due to medical comorbidities and/or frailty. This case series aims to investigate outcomes for patients undergoing craniectomy and soft tissue reconstruction. METHOD: Patients who underwent craniectomy and soft tissue reconstruction for invasive NMSC with calvarium or periosteal invasion between 2016 and 2022 were included...
February 6, 2024: Journal of Plastic, Reconstructive & Aesthetic Surgery: JPRAS
https://read.qxmd.com/read/38385179/eight-weeks-of-exercise-intervention-improve-visuomotor-and-functional-capacity-performance-and-physiological-profile-in-a-choroidal-melanoma-patient
#40
JOURNAL ARTICLE
Michael Mendes Wefelnberg, Madeline Moll, Philipp von Stein, Henning Guthoff, Ludwig M Heindl, Philomena Wawer Matos Reimer, Alexander C Rokohl, Michael Simon, Damir Zubac, Freerk T Baumann
The aim of this case-study was to investigate the effects of an 8-week combined exercise intervention, consisting of visual-coordinative and high-intensity interval training (HIIT), on the physical and visuomotor-functional capacity, performance, and physiological profile of a moderately active 29-year-old man diagnosed with choroidal melanoma of the left eye. Data were collected on three occasions: at the initial diagnosis (T0), after hospitalization and radiotherapy treatment (T1), and following the recovery through the exercise intervention (T2), spanning a total of 17 weeks...
February 22, 2024: Journal of Applied Physiology
keyword
keyword
160662
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.